The second biennial meeting of the Mycoses Study Group Education and Research Consortium (MSGERC) took place in Big Sky, Montana, from September 25 through 28, 2018. To the clinician and clinician/educator, this meeting serves as an up-to-date review of critical issues in mycology provided by the world's leading experts. To the clinical and translational researcher, it provides an opportunity to share and discuss data, to network with other investigators, and to develop new research questions. For the trainee, the meeting serves as a clinical update, but more importantly, it provides a forum to meet with many international leading authorities in clinical and applied mycology, and to discuss career goals and research ideas. To those associated with governmental agencies such as the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the Food and Drug Administration (FDA), it provides an opportunity to share insights, perspective, and priorities with investigators and representatives from industry. As such, we believe that the MSGERC Biennial Meeting is a nexus where clinicians, trainees, researchers, industry representatives, and governmental agencies can meet to discuss each of the key issues in mycology and set the research and education agenda for the next few years in an open forum.

中文翻译：

---

今日临床真菌学：真菌病研究小组教育与研究联盟（MSGERC）第二次两年一次会议的提要，2018年9月27日至30日，蒙大拿州大天空，拟议的全球研究议程。

Mycoses研究小组教育与研究联盟（MSGERC）第二次两年一次的会议于2018年9月25日至28日在蒙大拿州的大天空举行。对于临床医生和临床医生/教育者来说，该会议是最新的审查由世界一流专家提供的真菌学关键问题。对于临床和转化研究人员而言，它提供了一个共享和讨论数据，与其他研究人员建立网络并提出新研究问题的机会。对于受训者，该会议是临床更新，但更重要的是，它提供了一个论坛，可与许多临床和应用真菌学领域的国际领先机构举行会议，并讨论其职业目标和研究思路。对于那些与政府机构（例如疾病控制和预防中心（CDC））有关联的机构，美国国立卫生研究院（NIH）和食品药品管理局（FDA）提供了与研究人员和行业代表分享见解，观点和重点的机会。因此，我们认为MSGERC双年度会议是临床医生，受训人员，研究人员，行业代表和政府机构之间的联系，可以讨论真菌学中的每个关键问题，并确定今后几年的研究和教育议程。一个开放的论坛。